DFDA

Speech Therapy

Treatment for Orofacial Clefts

Typical Dosage: 1-2 sessions per week, 30-60 minutes each

Effectiveness
80%
Safety Score
95%
Clinical Trials
1,500
Participants
150K

Comparative Safety Scale(Higher is safer)

Cyanide☠️
Meth💀
Cigarettes🚬
Chemo☢️
Alcohol🍺
Morphine💊
Antibiotics💉
Tylenol💊
Exercise🏃
Water💧
95
DangerousModerateSafe
Treatment Details
Dosage Range
1-2 sessions per week, 30-60 minutes each
Time to Effect
Gradual over months to years
Treatment Duration
Variable, 6 months to several years (1-2 sessions/week)
Evidence Quality
HIGH
Confidence Score
90%confidence in effectiveness data
Health Economics
Annual Cost of Care
Drug Cost:$0
Monitoring:$7,500
Side Effect Mgmt:$0
Total Annual:$7,500
Cost-Effectiveness Analysis
Cost-Effectiveness Rating
GOOD
ICER
$97,500/QALY
QALYs Gained
1.8
Outcome-Based Costs
Cost per Responder
$8,824
Cost per Remission
$12,500
Speech Therapy Outcomes

for Orofacial Clefts

Efficacy Outcomes
Overall Effectiveness
+80%
Response Rate
+85%
Remission Rate
+60%
Common Side Effects
Time commitment
+100%
Patient/family frustration
+30%
Limited progress (severe cases)
+10%

Sources:

asha.org
nih.gov
semanticscholar.org

WARNING: LIMITED TRIALS AVAILABLE

You can search for trials, but you probably can't join any because the 1% Treaty hasn't passed yet. Most trials are severely limited by lack of funding and bureaucratic barriers. Help change this!

Active Clinical Trials
No active trials currently recruiting for this treatment

No active trials found in ClinicalTrials.gov